During a meningococcal meningitis epidemic in Burkina Faso, households spent, on average, US$90 for treatment and other direct costs for family members with the disease. These costs, the equivalent of one third of the country’s annual GDP per capita, were in addition to the loss of income and assets from family members caring for patients.
Full Citation:
Colombini A, Badolo O, Gessner BD et al.. 2011. Costs and impact of meningitis epidemics for the public health system of Burkina Faso. Vaccine. 29(33).
Title of Article: Costs and impact of meningitis epidemics for the public health system of Burkina Faso
Author(s): Colombini A, Badolo O, Gessner BD et al.
Publication Year: 2011
Publication Name: Vaccine
Publication Volume: 29(33)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/21641952
DOI (Digital Object Identifier): 10.1016/j.vaccine.2011.05.058
Topics: Economics & Return on Investment
Disease Vaccines: Meningococcal disease / MenACWY
Immunization Terms: Impoverishment
Countries: Burkina Faso
WHO Regions: Africa